Yum China at $45.53 Faces Its Toughest Same-Store Test in Quarters
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
YUMC reports Q3 results on October 30, with the stock up 12.5% over the past month yet trading at a 27% discount to the analyst consensus target of $62.17, a gap that frames the print as a valuation catalyst rather than a positioning event.
Options traders are not bracing for trouble. The put/call ratio of 0.43 sits just above its 20-day average of 0.42, barely one standard deviation from normal, and well below the 52-week peak of 2.23. Call volume continues to dominate, suggesting the market is leaning into the rally rather than hedging against a reversal. The one-month surge to $45.53 came against a peer median gain of roughly 1.1% last week, with HTHT up 1.9% and MCD up 3.4%, so YUMC's broader monthly outperformance appears to reflect stock-specific re-rating rather than a sector tide.
Short interest reinforces that relaxed tone. At 1.6% of free float, the position is low, and it has eased 2.6% over the past week even as the one-month level rose 24.6%, that monthly build coinciding with the stock's sharp re-rating from lower levels. Borrowing costs have fallen 16.5% over the past month to 0.48%, and availability is extraordinarily loose at nearly 1,477% of outstanding short interest, meaning there are roughly fifteen shares available to borrow for every one currently lent out. There is no squeeze pressure, and no evidence of conviction on the short side.
The debate around the company centres on whether the China consumer is recovering fast enough to justify re-rating. A previous note flagged that domestic traffic remains under pressure from economic uncertainty, while forward earnings expectations were running at a roughly 40% year-on-year increase as of late August, well above what the stock's PE of 13.8x implies the market is willing to pay for. The EV/EBITDA multiple of 8.2x has expanded by around 1.5% over the past month, consistent with the price move, but still modest for a franchise operator of this quality. The factor score for EV/EBIT ranks in the 71st percentile, and the earnings surprise score ranks in the 69th, pointing to a management team with a recent habit of exceeding expectations. The analyst consensus, struck as of mid-October, is constructive, with no recent changes from bellwether firms within the past two weeks.
JPMorgan holds a 5.7% stake per its October 15 Schedule 13G/A filing, down from 7.6% previously, and Principal Global Investors sits at 5.5% per a November 2025 filing. Neither filing signals activist intent. No Schedule 13D has been filed on YUMC. The disclosure caveat applies: stakes are as last disclosed around the 5% threshold, and positions can fall below that level without a further filing.
Wikipedia attention for YUMC spiked to a z-score of 2.2 relative to its own prior 90 days as of late September, Wikimedia Foundation data shows. That reflects retail attention rather than a financial signal, but it is consistent with the stock drawing renewed interest during its October re-rating.
The October 30 print is primarily a test of whether same-store sales in China improved enough to justify the $45 price level, and whether management's commentary on the consumer outlook closes any part of the gap to that $62 consensus target.
Stocks in this article
See the live data behind this article on ORTEX.
Open YUMC on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:16
- Data as of
- 27 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.